BIOLIMUS A9™

  • 細胞増殖抑制性能を示すリムス系薬剤BA9
  • 高い親油性により、素早く組織に浸透し、細胞に取り込まれます
  • 高い局所的バイオアベイラビリティ:
  • 標的病変への持続的な薬剤のリリースが可能 8
  • 一般的なリムス系薬剤より半減期が長い 8

biofreedom-ultra

BA9™ drug 10 times more
lipophilic than Sirolimus

  • 特長
  • 特長

アイコン

BIOFREEDOM™
FAMILY CLINICAL PROGRAM

BioFreedom™ - Company Managed Trials

特長

11855-000-EN_Rev.03d8

  • 1. BioLimus-A9™ coated thin strut stents in High Bleeding Risk patients Oral abstract presentation Eberli R. PCR e-course 2020
  • 2. Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study. M.W. Krucoff. Circ Cardiovasc Interv. 2020 Apr;13
  • 3. ePoster Dr Saito Euro PCR 2017
  • 4. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective,
    multicenter BioFreedom USA clinical trial Waksman R. et al CRM 18 (2017) 475–481
  • 5. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents. Garot P et al. JACC VOL.6 9, NO.2 , 2017
  • 6. Main results of the BioFreedom QCA trial. Sabate M. PCR e-course 2020
  • 7. Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial Costa R et al. J Am Coll Cardiol Intv 2016;9:51–64

BioFreedom™ - Physician Managed Trials

with support from Biosensors International*

特長

11855-000-EN_Rev.03d8

  • *   Biosensors has provided financial support for these PITs
  • 6. Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirol
    Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial. Published online Jensen L. 10.1161/CIRCULATIONAHA.119.0
  • 7. Safety and efficacy of polymer-free Biolimus eluting stents in all-comer patients: The RUDI FREE study Sardella G, et al. EuroIn
  • 8. Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by lon
    assessments: the EGO-BIOFREEDOM study Lee SWL et al. EuroIntervention. 2018 Sep 20;14(7):780-788

BioFreedom™ - Trials

with no Biosensors International involvement

特長

11855-000-EN_Rev.03d8

  • 9. Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction
    in a metropolitan public hospital: The BESAMI MUCHO study Gaspardone A Catheter Cardiovasc Interv.2017;00:1–8
  • 10. Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk Windecker S, et al. N Engl J Med. 12th February 2020; 1-11

LinkedIn